Citalopram vs Nivolumab

Citalopram vs Nivolumab: Overview

This comparison examines the pharmacological differences between Citalopram and Nivolumab.

Mechanism of Action

Citalopram: Selective serotonin reuptake inhibitor (SSRI); racemic mixture with escitalopram as active S-enantiomer.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Citalopram — 35 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Citalopram — C20H21FN2O.

Molecular Weight: Citalopram — 324.3920 g/mol.

Type: Citalopram — Small molecule; Nivolumab — Antibody.